NCT06618482

Brief Summary

The use of adhesive bandages is a widely practiced technique in both clinical and sports settings. There is a great variety of materials used for bandaging, with multiple objectives: limiting movement, correcting joint positions, reducing pain, enhancing sports performance, and reducing the number of injuries. However, current knowledge about their potential effects is still limited, and more studies are needed to determine the most appropriate application parameters. For this reason, the objective of the study for which we request your collaboration is to determine to what extent the application of an adhesive bandage (neuromuscular tape) can influence muscle facilitation through fiber recruitment and strength development, to improve performance during exercise. The information derived from this research will provide a better understanding of the influence that an adhesive bandage (neuromuscular tape) can have on the neuromuscular system and on strength enhancement.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

September 30, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2024

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2024

Completed
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

14 days

First QC Date

September 18, 2024

Last Update Submit

September 25, 2024

Conditions

Keywords

KinesiotapeBandageTransverse AbdominalAbdominal Ultrasound

Outcome Measures

Primary Outcomes (1)

  • Muscle thickness of the transverse abdominis muscle

    Muscle thickness of the transverse abdominis muscle mesured with ultrasound

    30 minutes

Study Arms (2)

Low back kinesiotaping

EXPERIMENTAL
Procedure: Kinesiotaping

Transversus abdominis Kinesiotaping

EXPERIMENTAL
Procedure: Kinesiotaping

Interventions

KinesiotapingPROCEDURE

Low back kinesiotaping

Also known as: neuromuscular bandage
Low back kinesiotaping

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • The participants are members of the UVIGO who voluntarily participate in the study with an age between 18 and 35 years.
  • The participants are healthy subjects (men and women) of legal age.
  • All subjects must sign the informed consent prior to the experimentation.

You may not qualify if:

  • \- Suffering from skin disorders, fragile skin or allergy to adhesive bandages.
  • Elite athletes.
  • Excessive skin hair in the region to apply the bandage.
  • Receive a bandage in the abdominal or lumbar region two weeks prior to the experiment.
  • History of orthopedic/traumatic alterations in the lumbopelvic region (deformities, arthrodesis, arthropathy, muscle injuries, fracture or tendinopathy), neurological disorders (central or peripheral), systemic disorders, circulatory disorders (edema, heart failure, thrombosis, renal failure), or surgery in the abdominal-lumbar region in the last 6 months.
  • Perform abdominal or lumbar strength training 48 hours prior to the study.
  • Limitation greater than 50% in the flexion-extension range of motion of the lumbar spine.
  • Consumption of alcoholic beverages or medications 24 hours prior to the experimentation.
  • Pregnancy or having given birth in less than a year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Iria Da Cuña- Carrera

CONTACT

Mercedes Soto-González

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD

Study Record Dates

First Submitted

September 18, 2024

First Posted

October 1, 2024

Study Start

September 30, 2024

Primary Completion

October 14, 2024

Study Completion

October 16, 2024

Last Updated

October 1, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share